DRAK2-IN-1
DRAK2-IN-1, compound 16, is a potent, selective and ATP-competitive DRAK2 inhibitor with IC50and Kivalues of 3 nM and 0.26 nM, respectively. DRAK2-IN-1 also has inbitory effect on DRAK1 (IC50=51 nM) [1].
Product Specifications
CAS Number
[871837-60-4]
UNSPSC
12352005
Target
DAPK
Type
Reference compound
Related Pathways
Apoptosis
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/drak2-in-1.html
Purity
99.93
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CCCCC(NC1=CC2=C(NC(/C2=C3NC4=C(C=CC=C4)C\3=N\O)=O)C=C1)=O
Molecular Formula
C21H20N4O3
Molecular Weight
376.41
References & Citations
[1]Jung ME, et al.Discovery of indirubin derivatives as new class of DRAK2 inhibitors from high throughput screening.Bioorg Med Chem Lett. 2016 Jun 1;26 (11) :2719-23
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS9011282 Inquire
Rabbit anti-Schizosaccharomyces pombe (strain 972/24843)(Fission yeast) pkp1 Polyclonal Antibody
Ask
View Details 
035591-APC 200 µL
FCRL3, CT (FCRL3, FCRH3, IFGP3, IRTA3, SPAP2, Fc receptor-like protein 3, Fc receptor homolog 3, IFGP family protein 3, Immune receptor translocation-associated protein 3, SH2 domain-containing phosphatase anchor protein 2, CD307c) (APC) discontinued
Ask
View Details 